Literature DB >> 18597061

[Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery].

V Ghezel-Ahmadi1, V C Kürschner, A Fisseler-Eckhoff, J Schirren, J E Schmitz, T Obenhaus.   

Abstract

The case of a 69-year-old patient is reported with non-small cell lung cancer who underwent lobectomy with sleeve resection and postoperatively developed intermittent atrial tachyarrhythmia. The patient was treated with a beta-blocker and the class III antiarrhythmic drug amiodarone, which resulted in normal frequency sinus rhythm. After pharmacological saturation with amiodarone, fibrosis of the lungs developed with subsequent respiratory insufficiency. Despite maximum intensive care therapy the patient died 9 weeks after surgery of hypoxemia-related multiple organ dysfunction syndrome. Based on this case amiodarone-related pneumonitis will be discussed, which due to a lack of pathognomonic symptoms is often difficult to diagnose and for which there are few treatment options available. The differential diagnoses of pneumonitis will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597061     DOI: 10.1007/s00101-008-1407-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  30 in total

Review 1.  Early complications. Cardiac complications.

Authors:  H Asamura
Journal:  Chest Surg Clin N Am       Date:  1999-08

2.  Chest re-exploration for complications after lung surgery.

Authors:  H Sirbu; T Busch; I Aleksic; S Lotfi; W Ruschewski; H Dalichau
Journal:  Thorac Cardiovasc Surg       Date:  1999-04       Impact factor: 1.827

3.  Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.

Authors:  G Delle Karth; A Geppert; T Neunteufl; U Priglinger; M Haumer; M Gschwandtner; P Siostrzonek; G Heinz
Journal:  Crit Care Med       Date:  2001-06       Impact factor: 7.598

4.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.

Authors:  H F Clemo; M A Wood; D M Gilligan; K A Ellenbogen
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

5.  Amiodarone and the development of ARDS after lung surgery.

Authors:  W Van Mieghem; L Coolen; I Malysse; L M Lacquet; G J Deneffe; M G Demedts
Journal:  Chest       Date:  1994-06       Impact factor: 9.410

6.  Relationships between amiodarone dosage, drug concentrations, and adverse side effects.

Authors:  J J Heger; E N Prystowsky; D P Zipes
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

7.  Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment.

Authors:  E Antón Aranda; R Alkiza Basañez; Y Laplaza Jiménez
Journal:  Neth J Med       Date:  1998-09       Impact factor: 1.422

Review 8.  Cardiac arrhythmias.

Authors:  D Amar
Journal:  Chest Surg Clin N Am       Date:  1998-08

9.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

10.  Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

Authors:  J J Heger; E N Prystowsky; W M Jackman; G V Naccarelli; K A Warfel; R L Rinkenberger; D P Zipes
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

View more
  2 in total

Review 1.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

2.  Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection - A case report and review of recent literature.

Authors:  Heiko Baumann; Phillip Fichtenkamm; Thomas Schneider; Jürgen Biscoping; Michael Henrich
Journal:  Ann Med Surg (Lond)       Date:  2017-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.